• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

737例成人重症监护病房患者的血小板减少症:一项关于相关因素、药物、血小板输注及临床结局的真实世界研究。

Thrombocytopenia in 737 adult intensive care unit patients: A real-world study of associated factors, drugs, platelet transfusion, and clinical outcome.

作者信息

Zhang Man-Ka, Xu Tian-Qi, Zhang Xiao-Jing, Rao Zhi-Guo, He Xiao-Xu, Wu Mei-Qing, Li Zhou-Ping, Liu Yin, Yang Jing-Cheng, Gong Yi-Fan, Tang Ming, Xue Xiao-Yan

机构信息

Intensive Care Unit, Aerospace Central Hospital, Peking University Aerospace School of Clinical Medicine, Beijing, China.

出版信息

SAGE Open Med. 2020 Oct 7;8:2050312120958908. doi: 10.1177/2050312120958908. eCollection 2020.

DOI:10.1177/2050312120958908
PMID:33110602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7564627/
Abstract

OBJECTIVE

We aimed to identify and represent factors associated with thrombocytopenia in intensive care unit, especially the pathogens and drugs related to severe and extremely thrombocytopenia. Then, we aim to compare the mortality of platelet transfusion and non-transfusion in patients with different degrees of thrombocytopenia.

METHODS

We identified all thrombocytopenic patients in intensive care unit by using platelet-specific values and then extracted electronic health records from our Hospital Information System. Data were statistically analyzed with t test, chi-square test, and logistic regression.

RESULTS

We found that infections (32.7%) were the most frequent cause associated with thrombocytopenia, followed by sepsis shock (3.93%) and blood loss (2.99%). Meanwhile, antifungals ( = 0.002) and bacterial infection ( = 0.037) were associated with severe and extremely severe thrombocytopenia. Finally, we found that the mortality of platelet transfusion and non-transfusion in patients was statistically significant for patients with platelet counts between 30 and 49/nL (χ = 9.719,  = 0.002).

CONCLUSION

Infection and sepsis emerged as two primary factors associated with thrombocytopenia in intensive care unit. Meanwhile, antifungals and bacterial infection were associated with platelet counts less than 49/nL. Finally, platelet transfusion may be associated with reduced mortality in patients with platelet counts between 30 and 49/nL.

摘要

目的

我们旨在识别并呈现重症监护病房中与血小板减少相关的因素,尤其是与严重和极严重血小板减少相关的病原体和药物。然后,我们旨在比较不同程度血小板减少患者接受血小板输注和未接受血小板输注的死亡率。

方法

我们通过使用血小板特异性值识别重症监护病房中的所有血小板减少患者,然后从我们的医院信息系统中提取电子健康记录。数据采用t检验、卡方检验和逻辑回归进行统计分析。

结果

我们发现感染(32.7%)是与血小板减少相关的最常见原因,其次是脓毒症休克(3.93%)和失血(2.99%)。同时,抗真菌药物(P = 0.002)和细菌感染(P = 0.037)与严重和极严重血小板减少相关。最后,我们发现血小板计数在30至49/μL之间的患者接受血小板输注和未接受血小板输注的死亡率具有统计学意义(χ² = 9.719,P = 0.002)。

结论

感染和脓毒症是重症监护病房中与血小板减少相关的两个主要因素。同时,抗真菌药物和细菌感染与血小板计数低于49/μL相关。最后,血小板输注可能与血小板计数在30至49/μL之间的患者死亡率降低有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e72/7564627/7bdac3eaba6a/10.1177_2050312120958908-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e72/7564627/7bdac3eaba6a/10.1177_2050312120958908-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e72/7564627/7bdac3eaba6a/10.1177_2050312120958908-fig1.jpg

相似文献

1
Thrombocytopenia in 737 adult intensive care unit patients: A real-world study of associated factors, drugs, platelet transfusion, and clinical outcome.737例成人重症监护病房患者的血小板减少症:一项关于相关因素、药物、血小板输注及临床结局的真实世界研究。
SAGE Open Med. 2020 Oct 7;8:2050312120958908. doi: 10.1177/2050312120958908. eCollection 2020.
2
Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome.医学重症监护病房患者的血小板减少症:出血发生率、输血需求及预后。
Crit Care Med. 2002 Aug;30(8):1765-71. doi: 10.1097/00003246-200208000-00015.
3
Platelet counts and outcome in the pediatric intensive care unit.小儿重症监护病房中的血小板计数与预后
Indian J Crit Care Med. 2008 Jul;12(3):102-8. doi: 10.4103/0972-5229.43678.
4
Platelet transfusion and mortality in patients with sepsis-induced thrombocytopenia: A propensity score matching analysis.血小板输注与脓毒症相关血小板减少症患者的死亡率:倾向评分匹配分析。
Vox Sang. 2022 Oct;117(10):1187-1194. doi: 10.1111/vox.13335. Epub 2022 Jul 19.
5
Implications of thrombocytopenia and platelet course on pediatric intensive care unit outcomes.血小板减少症及血小板变化过程对儿科重症监护病房治疗结果的影响。
Pediatr Crit Care Med. 2008 Sep;9(5):502-5. doi: 10.1097/PCC.0b013e3181849af1.
6
Platelet Transfusion in Patients With Sepsis and Thrombocytopenia: A Propensity Score-Matched Analysis Using a Large ICU Database.脓毒症和血小板减少症患者的血小板输注:一项使用大型重症监护病房数据库的倾向评分匹配分析
Front Med (Lausanne). 2022 Feb 16;9:830177. doi: 10.3389/fmed.2022.830177. eCollection 2022.
7
[Risk factors of early septic shock-related thrombocytopenia and its impact on prognosis].[早期脓毒性休克相关血小板减少症的危险因素及其对预后的影响]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Aug;33(8):938-943. doi: 10.3760/cma.j.cn121430-20210112-00036.
8
Organism-specific platelet response and factors affecting survival in thrombocytopenic very low birth weight babies with sepsis.有败血症的血小板减少极低出生体重儿的机体特异性血小板反应和影响生存的因素。
J Perinatol. 2009 Oct;29(10):702-8. doi: 10.1038/jp.2009.72. Epub 2009 Jun 25.
9
The effect of recombinant human thrombopoietin (rhTPO) on sepsis patients with acute severe thrombocytopenia: a study protocol for a multicentre randomised controlled trial (RESCUE trial).rhTPO 对脓毒症伴急性重度血小板减少症患者的影响:一项多中心随机对照试验研究方案(RESCUE 试验)。
BMC Infect Dis. 2019 Sep 6;19(1):780. doi: 10.1186/s12879-019-4388-2.
10
Thrombocytopenia in Paediatric ICU: Incidence, Transfusion Requirement and Role as Prognostic Indicator.儿科重症监护病房中的血小板减少症:发病率、输血需求及作为预后指标的作用
J Clin Diagn Res. 2015 Dec;9(12):SC05-7. doi: 10.7860/JCDR/2015/14590.6921. Epub 2015 Dec 1.

引用本文的文献

1
Platelets in infection: intrinsic roles and functional outcomes.感染中的血小板:内在作用与功能结果
Front Immunol. 2025 Jul 7;16:1616783. doi: 10.3389/fimmu.2025.1616783. eCollection 2025.
2
The clinical significance of thrombocytopenia in sepsis and septic shock: a systematic review and meta-analysis.脓毒症和脓毒性休克中血小板减少症的临床意义:一项系统评价和荟萃分析。
BMC Anesthesiol. 2025 Jul 1;25(1):327. doi: 10.1186/s12871-025-03188-7.
3
Incidence, Risk Factors, and Outcomes of Thrombocytopenia in Older Medical Inpatients: A Prospective Cohort Study.

本文引用的文献

1
Prophylactic use of platelets in critically ill patients with thrombocytopaenia: A retrospective two-centre observational study.血小板预防治疗血小板减少危重症患者:一项回顾性的两中心观察性研究。
J Crit Care. 2020 Jun;57:157-167. doi: 10.1016/j.jcrc.2020.03.003. Epub 2020 Mar 5.
2
Linezolid-induced thrombocytopenia increases mortality risk in intensive care unit patients, a 10 year retrospective study.利奈唑胺所致血小板减少症增加重症监护病房患者的死亡风险:一项10年回顾性研究
J Clin Pharm Ther. 2019 Feb;44(1):84-90. doi: 10.1111/jcpt.12762. Epub 2018 Sep 22.
3
Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
老年内科住院患者血小板减少症的发病率、危险因素及结局:一项前瞻性队列研究
Hematol Rep. 2024 Dec 13;16(4):804-814. doi: 10.3390/hematolrep16040076.
4
Platelet Transfusion in Patients With Sepsis and Thrombocytopenia: A Propensity Score-Matched Analysis Using a Large ICU Database.脓毒症和血小板减少症患者的血小板输注:一项使用大型重症监护病房数据库的倾向评分匹配分析
Front Med (Lausanne). 2022 Feb 16;9:830177. doi: 10.3389/fmed.2022.830177. eCollection 2022.
癌症患者血小板输注:美国临床肿瘤学会临床实践指南更新。
J Clin Oncol. 2018 Jan 20;36(3):283-299. doi: 10.1200/JCO.2017.76.1734. Epub 2017 Nov 28.
4
Guidelines for the use of platelet transfusions.血小板输注的使用指南。
Br J Haematol. 2017 Feb;176(3):365-394. doi: 10.1111/bjh.14423. Epub 2016 Dec 23.
5
AAGBI guidelines: the use of blood components and their alternatives 2016.AAGBI 指南:血液成分及其替代品的使用 2016 年版。
Anaesthesia. 2016 Jul;71(7):829-42. doi: 10.1111/anae.13489. Epub 2016 Apr 8.
6
Drug-induced thrombocytopenia in the critically ill: a case-control study.危重症患者药物性血小板减少症:一项病例对照研究。
Ann Pharmacother. 2014 Jun;48(6):697-704. doi: 10.1177/1060028013519065. Epub 2014 Mar 24.
7
Thrombocytopenia.血小板减少症
Crit Care Nurs Clin North Am. 2013 Dec;25(4):427-34, v. doi: 10.1016/j.ccell.2013.08.003. Epub 2013 Oct 20.
8
[Patient Blood Management : three pillar strategy to improve outcome through avoidance of allogeneic blood products].[患者血液管理:通过避免使用异体血制品改善预后的三大支柱策略]
Anaesthesist. 2013 Jul;62(7):519-27. doi: 10.1007/s00101-013-2199-1.
9
Blood component transfusion in critically ill patients.危重症患者的血液成分输血。
Curr Opin Crit Care. 2013 Aug;19(4):326-33. doi: 10.1097/MCC.0b013e3283632e56.
10
Thrombocytopenia in the critically ill: prevalence, incidence, risk factors, and clinical outcomes.危重症患者血小板减少症:患病率、发病率、危险因素和临床结局。
Can J Anaesth. 2013 Jul;60(7):641-51. doi: 10.1007/s12630-013-9933-7. Epub 2013 Apr 25.